Infectious Diseases News

Hepatitis C virus infection screening recommendationsJun 26, 2013
Baylor College of Medicine experts are supporting the latest recommendations by the Centers for Disease Control and Prevention regarding screening for hepatitis C virus infection.
Baylor pediatric HIV/AIDS program expands in LesothoJun 12, 2013
The Baylor College of Medicine International Pediatric AIDS Initiative (BIPAI) at Texas Children's Hospital will expand its clinical and educational efforts to reach the most remote villages of Lesotho with the opening of two new satellite clinical centers
Botswana-Baylor pediatric HIV/AIDS program celebrates 10th anniversaryJun 11, 2013
The Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital opened its first clinic 10 years ago in the region of Africa hardest hit by pediatric AIDS.
Kline to receive humanitarian awards from Houston-Galveston Schweitzer Fellows ProgramApr 16, 2013
Kline is being honored for his extensive efforts to address pediatrics HIV/AIDS in Sub-Saharan Africa and global health.
Study shows HIV treatment outcomes of undocumented Hispanic patientsMar 28, 2013
Previous research has shown that the undocumented Hispanic population is fearful of reaching out for publically funded healthcare.
Food availability linked with poor outcomes for HIV-positive childrenFeb 6, 2013
Food insecurity can lead to patients skipping their antiretroviral medications, medications may not be absorbed as well on empty stomach.
Experts offer important reminders on World AIDS DayNov 30, 2012
BCM experts stress reduce risky behaviors, know your HIV status.
West Nile Virus Q&AAug 30, 2012
BCM experts answer questions about West Nile Virus.
Experts encourage screening West Nile patients for kidney diseaseJul 12, 2012
BCM study finds the prevalence and progression of kidney disease in those previously infected with West Nile virus.
Baylor College of Medicine receives over $6 million from NIH to develop SARS vaccineMay 22, 2012
SARS vaccine endeavor is BCM's first major effort to develop a vaccine for a potential public health emergency threat in U.S.